10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001035267-22-000128`
Period End Date	20220630
Filing Date	20220722
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	isrg-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 100 Cash Flow Statement 70

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.29B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.54B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.90B	USD	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.91B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$782.70M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$838.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$724.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$587.10M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$271.10M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	357.70M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$292.60M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	357.10M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$6.29B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.84B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	357.10M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	357.70M	shares	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$2.11B	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.88B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$3.74B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$4.42B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$441.40M	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$515.90M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$633.20M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$700.40M	USD	Point-in-time
Goodwill	`Goodwill`	$343.60M	USD	Point-in-time
Goodwill	`Goodwill`	$349.10M	USD	Point-in-time
Total assets	`Assets`	$13.71B	USD	Point-in-time
Total assets	`Assets`	$13.55B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$149.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$121.20M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$350.10M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$278.60M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$377.20M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$376.30M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$370.40M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$301.30M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.15B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.18B	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$447.80M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$453.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.62B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.60B	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2022, and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of June 30, 2022, and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 357.1 shares and 357.7 shares issued and outstanding as of June 30, 2022, and December 31, 2021, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Common stock, 600.0 shares authorized, $0.001 par value, 357.1 shares and 357.7 shares issued and outstanding as of June 30, 2022, and December 31, 2021, respectively	`CommonStockValue`	$400.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$7.16B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$7.48B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.76B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$4.68B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$11.40M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$24.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-110.70M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-24.20M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-144.20M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$10.30M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$12.02B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$11.90B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$59.40M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$50.40M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.95B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.88B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.76B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.16B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.08B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$13.55B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$13.71B	USD	Point-in-time

Income Statement 100 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.46B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.76B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.01B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.52B	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$829.80M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$440.30M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$976.80M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$498.80M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.93B	USD	2 Qtrs
Gross profit	`GrossProfit`	$2.03B	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.02B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.02B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$809.50M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$676.20M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$418.40M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$350.20M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$162.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$207.30M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$322.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$417.80M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$998.30M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$625.70M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$512.50M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.23B	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$928.00M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$805.70M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$397.60M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$511.20M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$3.60M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$9.30M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$47.00M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$15.00M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$809.30M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$406.90M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$975.00M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$526.20M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$93.30M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$126.30M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$3.20M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$16.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$683.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$313.60M	USD	1 Quarter
Net income	`ProfitLoss`	$958.20M	USD	2 Qtrs
Net income	`ProfitLoss`	$523.00M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.60M	USD	2 Qtrs
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.80M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.80M	USD	1 Quarter
Less: net income attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.70M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$943.50M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$517.20M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$307.80M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$673.40M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.66	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.86	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.45	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.88	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.42	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.85	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.59	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.84	USD	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	358.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	355.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	355.70M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	358.10M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	363.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	365.30M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	364.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	364.50M	shares	2 Qtrs
Change in unrealized gains (losses) on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.00M	USD	2 Qtrs
Change in unrealized gains (losses) on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$4.40M	USD	1 Quarter
Change in unrealized gains (losses) on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$5.40M	USD	2 Qtrs
Change in unrealized gains (losses) on hedge instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-100.00K	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-6.00M	USD	1 Quarter
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-124.10M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-16.00M	USD	2 Qtrs
Change in unrealized losses on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-33.40M	USD	1 Quarter
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	2 Qtrs
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.50M	USD	1 Quarter
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.40M	USD	1 Quarter
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.10M	USD	2 Qtrs
Change in prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Change in prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-100.00K	USD	1 Quarter
Change in prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-100.00K	USD	2 Qtrs
Change in prior service cost for employee benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-200.00K	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-14.90M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-120.60M	USD	2 Qtrs
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-34.50M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.60M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$521.40M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$562.40M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$943.30M	USD	2 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$279.10M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$14.40M	USD	2 Qtrs
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$4.80M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$5.30M	USD	1 Quarter
Less: comprehensive income attributable to noncontrolling interest	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest`	$9.00M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$928.90M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$274.30M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$516.10M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$553.40M	USD	2 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$683.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$313.60M	USD	1 Quarter
Net income	`ProfitLoss`	$958.20M	USD	2 Qtrs
Net income	`ProfitLoss`	$523.00M	USD	1 Quarter
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$132.80M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`DepreciationandGainLossonDispositionofPropertyPlantEquipment`	$157.50M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$7.60M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$12.30M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$14.50M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$6.20M	USD	1 Quarter
Gain on sale of business	`GainLossOnSaleOfBusiness`	$3.80M	USD	2 Qtrs
Gain on sale of business	`GainLossOnSaleOfBusiness`	-	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$4.30M	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-33.80M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$40.10M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$24.00M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$247.50M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$211.30M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$10.00M	USD	2 Qtrs
Amortization of contract acquisition assets	`CapitalizedContractCostAmortization`	$13.60M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$59.60M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$56.00M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$245.50M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$92.40M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$90.10M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$177.00M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$38.20M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$12.40M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-71.50M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$19.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$10.60M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-17.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$19.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$669.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.02B	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.38B	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$3.51B	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	-	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$72.10M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$2.60B	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.87B	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$134.30M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$225.60M	USD	2 Qtrs
Acquisition of businesses, net of cash, and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.70M	USD	2 Qtrs
Acquisition of businesses, net of cash, and other investing activities	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.80M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-981.70M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$251.50M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$106.60M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$153.70M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$187.90M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$179.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$606.60M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$9.70M	USD	2 Qtrs
Payment of deferred purchase consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$3.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-43.90M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-682.00M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.00M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.60M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.90M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$245.20M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.64B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.31B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.63B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.55B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.64B	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.